Showing 1 - 1 results of 1 for search 'Marc W. Retter', query time: 0.01s Refine Results
  1. 1
    Translational findings support regimen selection for first‐in‐human study of ubamatamab (MUC16 × CD3 bispecific antibody) in patients with recurrent ovarian cancer

    Translational findings support regimen selection for first‐in‐human study of ubamatamab (MUC16 × CD3 bispecific antibody) in patients with recurrent ovarian cancer by Min Zhu, Priyanka Madia, Alison Crawford, Jurriaan Brouwer‐Visser, Pamela Krueger, Lauric Haber, Mary Peterman, Thomas S. Uldrick, Elizabeth Miller, John D. Davis, Marc W. Retter

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: